🇺🇸 FDA
Patent

US 10889556

Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease

granted A61PA61P31/16

Quick answer

US patent 10889556 (Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease) held by The Regents of the University of California expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P31/16